Transcriptome profiling has been shown really useful in the understanding of the aging 1 process. To date, transcriptomic data is the second most abundant omics data type without any further retraining. In this paper, we develop a transcriptomic deep-learned 6 age predictor. Deep neural networks (DNN) are trained and tested on more than 6 000 7 blood gene expression samples from 17 datasets. We apply methods based on output 8 derivatives of DNN to rank input genes by their importance in age prediction and reduce 9 the dimensional of the data. We also show that batch effect in transcriptome datasets of 10 healthy humans is indeed significant, but the existing normalization techniques, while 11 removing technical variation quite effectively, also remove age-associated changes. So 12 robust methods of age prediction are needed. 
Introduction

14
The rates of aging may vary substantially among the different individuals and population 15 groups and are significantly influenced by the environmental and hereditary factors. 16 Multiple attempts have been made to develop the biologically-relevant biomarkers of 17 human aging. 18 However, the biomarkers proposed so far usually focus on monitoring a restricted 19 number of processes known for being directly correlated with the chronological age 20 such as the telomere length-based or DNA methylation. There is a need for the 21 biologically-relevant quantifiable, interpretable and therapeutically-targetable multi- 22 modal biomarkers of aging. Even though these clocks were developed using traditional 23 machine learning approaches as a linear regression with regularization the results suggest 24 1/10 that gradual changes during aging can be tracked using various data types with reasonable 25 accuracy.
26
Previous studies demonstrated age-associated changes in the transcriptome 27 of model organisms [1] and multiple human tissues [2, 3, 4] . In 2015, Peters and 28 colleagues performed the massive analysis of transcriptional profiles of aging and used 29 six blood expression profiles (7,074 samples in total) to build a predictor of age with 30 leaving a dataset out as validation [3] . Using elastic-net regularized linear regression, 31 their approach achieved an average MAE of 7.8 years. In the analysis, 1,497 genes were 32 identified as age-related. In 2018, Mamoshina et al proposed a panel of transcriptomic 33 age predictors and the approach of comparing different methods of selecting age-related 34 genes [4] . A deep neural network was the most accurate age predictor showing the 35 accuracy of 0.91 in terms of Pearson correlation and mean absolute error of 6.14 years. 36 Further validation on the external GTEx dataset showed the accuracy of 0.80 with 37 respect to the actual age bin prediction. Another promising finding was that the list 38 of the features most relevant to age prediction identified by the deep neural network is 39 the closest results to the final consensus ranking produced by other ML age predictors 40 suggesting the superior generalization abilities.
41
However, most the age predictors so far use a limited number of samples from a 42 relatively small cohort of people for independent validation. The impact of the technical 43 variability or so-called batch effect on the age prediction also remains largely unaddressed 44 in the literature. This remains a key challenge in developing of aging biomarkers that 45 can be used in the clinical setting as they should robustly predict the age of previously 46 unseen samples from an independent dataset.
47
In this work, we decided to use deep learning models for predicting age of 48 humans by their gene expression profiles as they demonstrated impressive results on 49 blood biochemistry and cell counts [5, 6, 7] , transcriptomics [4] , microbiome [8] , facial 50 images [9] , bone X-ray images [10] , brain MRI images [11] .
51
Here we firstly collect a large dataset (6465 samples from 17 datasets) of 52 transcriptomic datasets of healthy and diseased human blood samples profiled using two 53 microarray platforms (Illumina HT12 v3.0 and v4.0). We then identify the technical 54 variability in blood transcriptome and showing that has a stronger impact on expression 55 than disease state or age. We apply several normalization techniques, showing that 56 while some of them are quite effective in removing the batch effect, they also mitigate 57 age-associated changes in the blood transcriptome.
58
Materials and Methods
59
Data
60
Gene expression profiles were collected from the publicly available repository Gene 61 Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/). In total, we analyzed 6465 62 transcriptomic samples, labeled according to the chronological age of the tissue samples' 63 donors, from 17 datasets ( To evaluate the performance of the age predictors robustly, we selected three datasets as 66 external testing sets. We also selected only samples of healthy subjects for the training 67 purposes, for age predictors to fit to age-associated changes in the transcriptome, rather 68 than disease-associated changes.
69
Normalization techniques
70
We compare non-normalized data (raw) to the following commonly used for gene expres-71 sion normalization methods: 
where g is the gene to normalize, rg is the reference gene (we choose C1ORF 43), 75 b is a some batch (GEO in our case). Reference genes or housekeeping genes should have 76 the constant level of the expression across different tissues and experimental designs, 77 diseases. Here we explored the Chromosome 1 Open Reading Frame 43 (C1orf43) gene 78 as a reference one (Figure 1) , that has been shown to have the most stable expression in 79 different human tissue and experiments [12] . 2. Cross-platform normalization method (XPN) proposed by Shabalin et al [13] . 81 3. Quantile normalization (QN) [14] 4. Distribution Transformation (DisTran) [15] 83
In contrast to RefGenNorm method, which is independent of other datasets, 84 the latter three methods require the reference dataset for data transformation. Here we 85 have selected GSE65907 as the most comprehensive one. We used R implementation of 86 XPN, QN and DisTran normalizations developed by Rudy et al [16] .
87
Despite applying normalization provided above, there are a lot of outliers left in 88 the normalized data. To handle it we used the standard technique for outliers detection 89 and exclusion called three-sigma rule [17] . We adapted this rule for our large dimensional 90 data (13454 genes) and classified sample as an outlier if it did not satisfy the three-sigma 91 rule over more than 99% of genes within each of four presented tissues. Without such 92 an adaptation we would lose more than half of the data.
93
Regression model implementation
94
We adapted a deep feed-forward neural network with a weighted layer providing a way to 95 rank the input features and ElasticNet-based regularization to this weighted layer provid-96 ing the ability to control sparsity/smoothness of weights [18] . We build and train models 97 using Keras (https://keras.io) library with Tensorflow (https://www.tensorflow.org/) 98 backend. Grid search over a space of model parameters with five-fold cross-validation 99 4/10 was used in order to find the best performing neural network architecture. The best 100 model was the one trained on 1000 selected genes (by deep feature selection method) and 101 has four layers with accordingly 800, 700, 600 and 500 neurons, Exponential Linear Unit 102 (ELU) [19] activation function after each hidden layer. Also, we used Adam [20] algorithm 103 for loss function optimization. For the purposes of regularization, we used dropout [21] 104 with 15% probability after each layer and combined ridge and lasso regularization with 105 10e −6 coefficients as additional loss term.
106
All experiments were conducted using an NVIDIA 1080Ti (Pascal) graphics 107 processing unit.
108
Model evaluation
109
We used the following metrics to evaluate the accuracy of age prediction models:
whereŷ i is a predicted age of a sample i, y i is the chronological age value of 112 a sample i, and N is a number of samples. M AE demonstrates average disagreement 113 between the chronological age and the predicted age. M AE of 0 means that the predicted 114 age and actual age are in a perfect agreement. 
Coefficient of determination:
where y i is the chronological age value of a sample i,ŷ i is the predicted age 118 value of a sample i, andȳ the mean chronological age in the distribution. R 2 shows the 119 percentage of variance explained by the regression between predicted and actual age. R 
Results
122
To examine associations between transcriptional changes in blood and chronological 123 age, we collected and analyzed 17 datasets. We collected 6465 samples of 13454 gene 124 expression values. The mean age of the collected samples was 61 years (Figure 2 ).
125
To distinguish batch effect from biological differences between different samples, 126 we performed t-Distributed Stochastic Neighbor Embedding (t-SNE) [22] and visualized 127 first two components of the manifold (Figure 3) . We compare several methods of adjusting 128 for batch effect. Compared to other methods, the XPN algorithm demonstrated great 129 improvement in batch effect removal, improving the entanglement of datasets (Figure 3) . 130 Age prediction results are summarized in Table 2 and showed in Figure 4 . 131 Baseline accuracy, where all samples are predicted as the median for distribution, is 132 8.14 years in terms of M AE and R 2 of 0.50 on the testing set and 9.07 M AE and 133 R 2 of 0.12 on the training set. DisTran method achieved the highest accuracy on 134 cross-validation compared to other methods (M AE of 5.05 years and R 2 of 0.70) and 135 the accuracy lower than the baseline on testing set (M AE of 9.29 and R 2 of 0.44). Table 2 . The performance of models trained on the five data before (Raw) and after cross-dataset normalization (RefGenNorm, XPN, QN, DisTran, See Methods for details).
We compared the batch effect for the top 10, 50, 100, 500 and 1000 the most 145 important genes for the age prediction identified by the model (Figure 5 ). Interestingly, 146 top-ranked genes (up to 20) are not related to batch, suggesting that DNNs still capture 147 genes that are strongly related to age rather than batch effect. It is critical because age 148 Figure 3 . Visualization of presence of batch effect in raw and normalized datasets. RAW is for raw data, DIST is for data normalized with Distribution Transformation. REF is for normalization by Reference Gene. XPN is for cross-platform normalization method proposed by Shabalin et al [13] . QN is for quantile normalization.
distributions of different datasets are indeed different and could bring certain bias.
149
Discussion
150
In this article, we illustrated the size of the batch effect in 17 publicly available gene 151 expression datasets of healthy human blood. We compared several standard normalization 152 methods with non-transformed data, showing that normalization by reference gene 153 returning the best results in terms of accuracy of age prediction. We also showed that 154 while some methods are removing batch effect significantly, also removing age-related 155 changes. Given the magnitude of batch effect in transcriptomic datasets and that, 156 cross-validation cannot replace independent-data validation for transcriptomic aging 157 biomarkers.
158
Effective batch-effect removal techniques remains a key challenge for transcrip-159 tomic aging markers. Figure 4 . Actual vs. predicted age plots on cross-validation and testing sets before and after normalization. RAW is for raw data, DIST is for data normalized with Distribution Transformation. REF is for normalization by Reference Gene. XPN is for cross-platform normalization method proposed by Shabalin et al [13] . QN is for quantile normalization.
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